Rock Springs Capital LLC

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Related People
Fund Service Providers
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Rock Springs Capital LLC
CIK #0001595725, 0001735397
Sector Form 13F Holdings Value ($B)
Revolution Medicines Inc 0.1
Lilly Eli & Co 0.1
Synta Pharmaceuticals Corp 0.1
Mirum Pharmaceuticals Inc 0.1
Argenx SE 0.1
Rhythm Pharmaceuticals Inc 0.1
Insmed Inc 0.1
Ascendis Pharma A/S 0.0
Xenon Pharmaceuticals Inc 0.0
Desert Gateway Inc 0.0
View All
Holdings by Sector ($B)
6.04.83.62.41.20.02013201720222027
EDGAR Form CIK 2011 - 2026
13F-HR [0001595725]
3 [0001595725]
4 [0001595725]
SC 13G [0001595725]
3 [0001735397]
4 [0001735397]
Form 13D/13G Filer Form 13D/13G Subject Filed
Rock Springs Capital Management LP Aclaris Therapeutics Inc [2024-11-22]
Rock Springs Capital Management LP Travere Therapeutics Inc [2024-05-01]
Rock Springs Capital Management LP Xilio Therapeutics Inc [2024-02-14]
Rock Springs Capital Management LP Agios Pharmaceuticals Inc [2023-02-14]
Rock Springs Capital Management LP Aeglea Biotherapeutics Inc [2023-02-14]
Rock Springs Capital Management LP Inozyme Pharma Inc [2022-04-25]
Rock Springs Capital Management LP Mereo Biopharma Group PLC [2022-02-15]
Rock Springs Capital Management LP Tempest Therapeutics Inc [2022-01-03]
Rock Springs Capital Management LP Compass Therapeutics Inc [2021-12-30]
Rock Springs Capital Management LP Tempest Therapeutics Inc [2021-07-08]
View All
Form 3/4/5 Subject 2011 - 2026
Rock Springs Capital Master Fund LP
Rock Springs Capital Management LP
Rock Springs Capital LLC
Tempest Therapeutics, Inc.
Xilio Therapeutics, Inc.
Four Pines Master Fund LP
Theseus Pharmaceuticals, Inc.
Verve Therapeutics, Inc.
Atea Pharmaceuticals, Inc.
Inozyme Pharma, Inc.
View All
Terms | Privacy | Providers | Guide
tony@aum13f.com